Methods of Using Adenoviral Vector to Induced an Immune Response Read more about Methods of Using Adenoviral Vector to Induced an Immune Response European Patent12180322.5Filed on 2005-04-12
IMMUNOGENS BASED ON AN HIV-1 V1V2 SITE-OF-VULNERABILITY Read more about IMMUNOGENS BASED ON AN HIV-1 V1V2 SITE-OF-VULNERABILITY Patent Cooperation TreatyPCT/US2012/054295Filed on 2012-09-07
CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS Read more about CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS US Patent 8,715,686Filed on 2012-08-14
Method for Using Adenoviral Vectors to Induce an Immune Response Read more about Method for Using Adenoviral Vectors to Induce an Immune Response US Application 13/568,239Filed on 2012-08-07
LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE Read more about LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE US Patent 9,255,252Filed on 2012-10-02
Human Parainfluenza Viruses Having Separated P and C Genes Read more about Human Parainfluenza Viruses Having Separated P and C Genes United Kingdom08780603.0Filed on 2008-05-08
Human Parainfluenza Viruses Having Separated P and C Genes Read more about Human Parainfluenza Viruses Having Separated P and C Genes France08780603.0Filed on 2008-05-08
Human Parainfluenza Viruses Having Separated P and C Genes Read more about Human Parainfluenza Viruses Having Separated P and C Genes Germany08780603.0Filed on 2008-05-08
Human Parainfluenza Viruses Having Separated P and C Genes Read more about Human Parainfluenza Viruses Having Separated P and C Genes Switzerland08780603.0Filed on 2008-05-08
Targeting Poly-gamma-glutamic acid to treat Staphylococcus Epidermidis and related infections Read more about Targeting Poly-gamma-glutamic acid to treat Staphylococcus Epidermidis and related infections US Patent 8,623,371Filed on 2012-07-20